These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 28716794)
21. Background paper to the recommendation for the preferential use of live-attenuated influenza vaccine in children aged 2-6 years in Germany. Falkenhorst G; Harder T; Remschmidt C; Terhardt M; Zepp F; Ledig T; Wicker S; Keller-Stanislawski B; Mertens T Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Nov; 56(11):1557-64. PubMed ID: 24170085 [TBL] [Abstract][Full Text] [Related]
22. Live attenuated influenza vaccine use and safety in children and adults with asthma. Duffy J; Lewis M; Harrington T; Baxter R; Belongia EA; Jackson LA; Jacobsen SJ; Lee GM; Naleway AL; Nordin J; Daley MF; Ann Allergy Asthma Immunol; 2017 Apr; 118(4):439-444. PubMed ID: 28390584 [TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine-naive children. Bracco Neto H; Farhat CK; Tregnaghi MW; Madhi SA; Razmpour A; Palladino G; Small MG; Gruber WC; Forrest BD; Pediatr Infect Dis J; 2009 May; 28(5):365-71. PubMed ID: 19395948 [TBL] [Abstract][Full Text] [Related]
24. A US postmarketing evaluation of the frequency and safety of live attenuated influenza vaccine use in nonrecommended children younger than 5 years: 2009-2010 season. Tennis P; Toback SL; Andrews EB; McQuay LJ; Ambrose CS Vaccine; 2012 Sep; 30(42):6099-102. PubMed ID: 22841479 [TBL] [Abstract][Full Text] [Related]
25. A Feasibility Trial of Home Administration of Intranasal Vaccine by Parents to Eligible Children. Jhaveri R; Allyne K Clin Ther; 2017 Jan; 39(1):204-211.e4. PubMed ID: 27938896 [TBL] [Abstract][Full Text] [Related]
26. A systematic review of the efficacy of live attenuated influenza vaccine upon revaccination of children. Caspard H; Heikkinen T; Belshe RB; Ambrose CS Hum Vaccin Immunother; 2016 Jul; 12(7):1721-7. PubMed ID: 26751513 [TBL] [Abstract][Full Text] [Related]
27. Efficacy of a single dose of live attenuated influenza vaccine in previously unvaccinated children: a post hoc analysis of three studies of children aged 2 to 6 years. Block SL; Toback SL; Yi T; Ambrose CS Clin Ther; 2009 Oct; 31(10):2140-7. PubMed ID: 19922885 [TBL] [Abstract][Full Text] [Related]
28. Do parents prefer inactivated or live attenuated influenza vaccine for their children? Santibanez TA; Kahn KE; Bridges CB Vaccine; 2018 Nov; 36(48):7300-7305. PubMed ID: 30340880 [TBL] [Abstract][Full Text] [Related]
29. Increasing uptake of live attenuated influenza vaccine among children in the United States, 2008-2014. Rodgers L; Pabst LJ; Chaves SS Vaccine; 2015 Jan; 33(1):22-4. PubMed ID: 25448098 [TBL] [Abstract][Full Text] [Related]
30. Live Attenuated Versus Inactivated Influenza Vaccine in Hutterite Children: A Cluster Randomized Blinded Trial. Loeb M; Russell ML; Manning V; Fonseca K; Earn DJ; Horsman G; Chokani K; Vooght M; Babiuk L; Schwartz L; Neupane B; Singh P; Walter SD; Pullenayegum E Ann Intern Med; 2016 Nov; 165(9):617-624. PubMed ID: 27538259 [TBL] [Abstract][Full Text] [Related]
31. Shedding of Ann Arbor strain live attenuated influenza vaccine virus in children 6-59 months of age. Mallory RM; Yi T; Ambrose CS Vaccine; 2011 Jun; 29(26):4322-7. PubMed ID: 21513761 [TBL] [Abstract][Full Text] [Related]
32. Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial. Nichol KL; Mendelman PM; Mallon KP; Jackson LA; Gorse GJ; Belshe RB; Glezen WP; Wittes J JAMA; 1999 Jul; 282(2):137-44. PubMed ID: 10411194 [TBL] [Abstract][Full Text] [Related]
33. The efficacy of intranasal live attenuated influenza vaccine in children 2 through 17 years of age: a meta-analysis of 8 randomized controlled studies. Ambrose CS; Wu X; Knuf M; Wutzler P Vaccine; 2012 Jan; 30(5):886-92. PubMed ID: 22155144 [TBL] [Abstract][Full Text] [Related]
34. Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children 2-17 years of age in 2013-2014 in the United States. Caspard H; Gaglani M; Clipper L; Belongia EA; McLean HQ; Griffin MR; Talbot HK; Poehling KA; Peters TR; Veney N; Ambrose CS Vaccine; 2016 Jan; 34(1):77-82. PubMed ID: 26589519 [TBL] [Abstract][Full Text] [Related]
35. An intercountry comparison of the impact of the paediatric live attenuated influenza vaccine (LAIV) programme across the UK and the Republic of Ireland (ROI), 2010 to 2017. Sinnathamby MA; Warburton F; Reynolds AJ; Cottrell S; O'Doherty M; Domegan L; O'Donnell J; Johnston J; Yonova I; Elgohari S; Boddington NL; Andrews N; Ellis J; de Lusignan S; McMenamin J; Pebody RG Influenza Other Respir Viruses; 2023 Feb; 17(2):e13099. PubMed ID: 36824392 [TBL] [Abstract][Full Text] [Related]
36. Randomized evaluation of live attenuated vs. inactivated influenza vaccines in schools (RELATIVES) pilot study: a cluster randomized trial. Kwong JC; Pereira JA; Quach S; Pellizzari R; Dusome E; Russell ML; Hamid JS; Feinberg Y; Winter AL; Gubbay JB; Sirtonski B; Moher D; Sider D; Finkelstein M; Loeb M; Vaccine; 2015 Jan; 33(4):535-41. PubMed ID: 25488331 [TBL] [Abstract][Full Text] [Related]
37. Live versus attenuated influenza vaccine uptake and post-vaccination influenza-like illness outcomes in HIV-infected US Air Force members. Menegay JL; Xu X; Sunil TS; Okulicz JF J Clin Virol; 2017 Oct; 95():72-75. PubMed ID: 28889083 [TBL] [Abstract][Full Text] [Related]
38. An integrated, multistudy analysis of the safety of Ann Arbor strain live attenuated influenza vaccine in children aged 2-17 years. Ambrose CS; Yi T; Falloon J Influenza Other Respir Viruses; 2011 Nov; 5(6):389-97. PubMed ID: 21668683 [TBL] [Abstract][Full Text] [Related]
39. Efficacy of a Russian-backbone live attenuated influenza vaccine among young children in Bangladesh: a randomised, double-blind, placebo-controlled trial. Brooks WA; Zaman K; Lewis KD; Ortiz JR; Goswami D; Feser J; Sharmeen AT; Nahar K; Rahman M; Rahman MZ; Barin B; Yunus M; Fry AM; Bresee J; Azim T; Neuzil KM Lancet Glob Health; 2016 Dec; 4(12):e946-e954. PubMed ID: 27746226 [TBL] [Abstract][Full Text] [Related]
40. Safety, vaccine virus shedding and immunogenicity of trivalent, cold-adapted, live attenuated influenza vaccine administered to human immunodeficiency virus-infected and noninfected children. King JC; Fast PE; Zangwill KM; Weinberg GA; Wolff M; Yan L; Newman F; Belshe RB; Kovacs A; Deville JG; Jelonek M; Pediatr Infect Dis J; 2001 Dec; 20(12):1124-31. PubMed ID: 11740317 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]